AI pioneer Geoffrey Hinton calls for drug-like regulation

By PulseAugur Editorial · [1 sources] · 2026-06-06 08:24

Geoffrey Hinton, a Nobel laureate and AI pioneer, has retired from active AI development but continues to advocate for the field's responsible progression. In a recent interview, he emphasized the critical need for independent testing, review, and regulation of AI applications, drawing parallels to the stringent processes applied to pharmaceutical drugs before market release. AI

IMPACT Suggests a new regulatory framework for AI applications, potentially impacting development and deployment timelines.

RANK_REASON Opinion piece by a credible voice on AI safety and regulation.

Read on Mastodon — fosstodon.org →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

COVERAGE [1]

Mastodon — fosstodon.org TIER_1 English(EN) · [email protected] · 2026-06-06 08:24

Superb interview of the brilliant Professor Hinton, AI pioneer, a Nobel Prize winner, and a professor emeritus at the University of Toronto. Retired from # AI d

Superb interview of the brilliant Professor Hinton, AI pioneer, a Nobel Prize winner, and a professor emeritus at the University of Toronto. Retired from # AI development, he remains active in the field as a spokesperson for its dangers - and how to steer it. I came away from it …

LINKS youtube.com/watch scicomm.xyz/@dcnorris

COVERAGE [1]

Superb interview of the brilliant Professor Hinton, AI pioneer, a Nobel Prize winner, and a professor emeritus at the University of Toronto. Retired from # AI d

RELATED ENTITIES

RELATED TOPICS